Commonwealth Equity Services
JNCE

Commonwealth Equity Services’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Commonwealth Equity Services’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,572
Closed -$28 – 3977
2023
Q1 		$28 Hold
15,572
– – ﹤0.01% 3640
2022
Q4 		$17K Buy
+15,572
New +$22.2K ﹤0.01% 3615

Other funds holding JNCE

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Commonwealth Equity Services's JNCE Position: Q2 2023 in Review

Commonwealth Equity Services sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 15,572 shares — an estimated $28 sold.

Commonwealth Equity Services first reported a position in JNCE in Q4 2022 and held it in 2 quarters. The position peaked at $17K in Q4 2022. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.

  • Commonwealth Equity Services reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 15,572 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $28.
  • Commonwealth Equity Services first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Commonwealth Equity Services's Jounce Therapeutics, Inc. Common Stock position peaked at $17K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Commonwealth Equity Services's 13F filing for Q2 2023, filed 10 Aug 2023.